Choi Garam, Bessman Nicholas J
Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA.
Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Nat Microbiol. 2025 May 21. doi: 10.1038/s41564-025-02001-y.
Iron is an essential dietary micronutrient for both humans and microorganisms. Disruption of iron homeostasis is closely linked, as both a cause and an effect, to the development and progression of gut microbiota dysbiosis and multiple diseases. Iron absorption in humans is impacted by diverse environmental factors, including diet, medication and microbiota-derived molecules. Accordingly, treatment outcomes for iron-associated diseases may depend on an individual patient's microbiome. Here we describe various iron acquisition strategies used by the host, commensal microorganisms and pathogens to benefit or outcompete each other in the complex gut environment. We further explore recently discovered microbial species and metabolites modulating host iron absorption, which represent potential effectors of disease and therapeutic targets. Finally, we discuss the need for mechanistic studies on iron-host-microbiome interactions that can affect disease and treatment outcomes, with the ultimate aim of supporting the development of microbiome-based personalized medicine.
铁是人类和微生物必需的膳食微量营养素。铁稳态的破坏与肠道微生物群失调和多种疾病的发生发展密切相关,既是原因也是结果。人类的铁吸收受到多种环境因素的影响,包括饮食、药物和微生物衍生分子。因此,与铁相关疾病的治疗结果可能取决于个体患者的微生物群。在这里,我们描述了宿主、共生微生物和病原体在复杂的肠道环境中为了彼此受益或相互竞争而采用的各种铁获取策略。我们进一步探索了最近发现的调节宿主铁吸收的微生物物种和代谢产物,它们代表了疾病的潜在效应物和治疗靶点。最后,我们讨论了对铁-宿主-微生物群相互作用进行机制研究的必要性,这种相互作用会影响疾病和治疗结果,最终目的是支持基于微生物群的个性化医学的发展。